IDSA has awarded 24 institutions the designation of Antimicrobial Stewardship Center of Excellence, including the Cleveland Clinic Abu Dhabi, making it the first hospital outside of the United States to receive the distinction.
IDSA has awarded 24 institutions the designation of Antimicrobial Stewardship Center of Excellence, including the Cleveland Clinic Abu Dhabi, making it the first hospital outside of the United States to receive the distinction.
IDSA supports guidance announced today by CDC recommending mask wearing in indoor public settings for all individuals in communities with substantial or high COVID-19 transmission rates, regardless of COVID-19 vaccination status.
IDSA and HIVMA joined more than 50 health care professional organizations in calling for requiring COVID-19 vaccinations for all health care workers.
IDSA commends appropriators in the U.S. House of Representatives for much-needed resources to bolster the domestic and global fight against COVID-19 and HIV, antibiotic research and development, strengthen global health security, and combat the effects of the opioid crisis.
More than 50 organizations working to end the HIV epidemic in the United States and globally are urging the White House to quickly nominate a leader for the U.S. President’s Emergency Plan for AIDS Relief as the Department of State’s U.S. Global AIDS Coordinator.
A new Clinical Infectious Diseases supplement takes a look back at the public health response to COVID-19 and what can be learned and built upon during the next phase of this pandemic and for future pandemics.
IDSA has developed a joint statement on considerations for COVID-19 vaccination as a condition of employment for healthcare workers with SHEA, HIVMA, the PIDS, APIC, AMDA, & SIDP.
The Infectious Diseases Society of America seeks candidates to serve in the position of editor-in-chief of Clinical Infectious Diseases.
New evidence-based clinical guidelines on the management of Clostridioides difficile infection (CDI) in adults have been developed by a multidisciplinary panel representing IDSA and SHEA.
Today the Global Coalition on Aging (GCOA) and IDSA launched the first-ever global AMR Preparedness Index, a first-of-its-kind evaluation of how the governments of the 11 largest global economies are living up to their commitments to address antimicrobial resistance (AMR).
The renewed introduction in the 117th Congress of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act, a bipartisan House and Senate bill to support the development of new antibiotics and promote their appropriate use, opens a critical opportunity for legislators to combat a growing and global public health crisis.
The IDSA Foundation announces a call for applications for the 2021 Microbial Pathogenesis in Alzheimer’s Disease Grant. The $1.7 million grant, an increase from $1 million in 2020, will fund the advancement of novel research into possible links between infectious diseases and the causation of Alzheimer’s disease.